Simon Redgrove


Simon Redgrove has built a strong reputation in the financial business community for nurturing the growth of businesses. He provides overall guidance to the board and brings a depth of knowledge of fostering companies like MedPharm through critical growth stages in their development. Simon was a founder and managing director of Cavanagh Group PLC in 1996 which he took to the AIM market in 2001 and sold to Close Brothers in 2011. Subsequently as Head of Advice at Close Brothers Asset Management he was instrumental in turning around the business. In 2015 Simon co-founded MunnyPot Ltd a low cost online investment service.

Dr. Andrew G. Muddle PhD

Chief Executive Officer and Co-founder

Andrew Muddle co-founded MedPharm in August 1999. He has spent over 25 years in pharmaceutical drug delivery in roles of increasing seniority. He has focused on ensuring MedPharm’s commercial proposals meet customers’ expectations and oversight of the consistent and impressive growth of the company from its very beginnings. Prior to MedPharm, Andrew was Technical Director (Pharmaceutical Development) at PowderJect Pharmaceuticals plc where he was pivotal in its IPO in 1997.

Prof. Marc Brown PhD CChem FRSC

Chief Scientific Officer and Co-founder

Prof. Marc Brown PhD CChem FRSC co-founded MedPharm in August 1999. He has been the guiding force behind all of MedPharm’s scientific developments and intellectual property. He has been Professor of Pharmaceutics in the School of Pharmacy, University of Hertfordshire since 2006 and has visiting/honorary professorships at the Universities of Reading and King's College London. He has over 200 publications and 26 patents describing his work. His research interests lie mainly in drug delivery to the skin, nail and airways. To date, he has been involved in the pharmaceutical development of over 38 products that are now on the market in Europe, America and Japan. Prior to MedPharm he was an academic in the Pharmacy Department at KCL.

Mike Nordsiek

Non-Executive Director

Mike Nordsiek has more than 35 years of business development, technical and management experience in the pharmaceutical industry, especially in the development of topical medicines. He has helped lead the global acquisition, licensing and development of products in the therapeutic areas of Dermatology, Women’s Health, Respiratory, and Cardio-Renal Health. As a co-founder of several speciality pharmaceutical companies over the last decade, he has successfully secured the funding, products and personnel necessary to build companies that have achieved up to $400M in yearly revenue. He obtained his BS in Pharmacy from the West Virginia University School of Pharmacy and is currently CEO of ProSoft Clinical.